It feels like there's nothing to talk about in the pharmaceutical
space these days other than the latest M&A bid. Just in the last day
and a half, investors have seen news on five completed or proposed
transactions. And I doubt the deal-making is done.
Continue here:
Healthcare Buyout Mania: Now What?
No comments:
Post a Comment